However, elevated Lp(a) among those with HeFH consistently raised risk of ASCVD endpoints in virtually every study.16, 17, 18, 19 Thus, elevated Lp(a) probably increases the likelihood that an individual with HeFH will be clinically recognized because they and their relatives are at higher risk of ASCVD. The gene discussed is LPA; the disease is atherosclerosis.